BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
Dr Kampani talks to ecancertv at AORTIC 2015 about 'telepathology' in Africa.
Telepahology involves experts from different countries being able to analyse slides from under the microscope via the internet.
This is extremely useful in countries were expertise in pathology are more scarce.
Dr Kampani talks with particular reference to his experience in Malawi, working with the University of Carolina in the USA.
I’m giving a talk about the telepathology conference which enhances the diagnosis of different diseases in sub-Saharan Africa.
How does it work?
The way it works is we normally have slides which we prepare, already stained, and then we scan them on the scanscope, the machine, and then we have an internet connection and there are some clinicians and pathologists the other side and anywhere in the world clinician pathologists can also see the slides and discuss whatever is happening.
What institutes are you working with?
I’m working for the UNC project, it’s a collaboration between the Ministry of Health in Malawi and the University of North Carolina in the US.
Do the US pathologists analysing the slides do so free of charge?
It’s for free.
Where does the funding for this project come from?
It comes from the University of North Carolina.
Is training required on the African end in order to use this procedure?
Yes, you have the training of how to operate the machine. But the challenge would be the procurement of the actual machine because it’s so expensive.
How has it benefitted patients so far?
You may want to know that in sub-Saharan Africa there are a few pathologists working on the ground. So if we don’t have a pathologist on site you can easily scan the slides and then have the pathologists from anywhere in the world consider the slides and provide a diagnosis.
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
Social determinants and survival outcomes in early-onset colorectal cancer in the US
Low frequency of dihydropyrimidine dehydrogenase variants in Mexican GI cancers should induce testing guideline reform
New classification for identifying HR myeloma based on cytogenetic abnormalities
Tele-mentoring: Impact of project ECHO
Predicting tumour mutations from pathology images may help increase personalised medicine utilisation
Cancer mutation prediction using artificial intelligence
Best practice in HRRm testing in patients with metastatic prostate cancer
SABCS 2023: Latest breast cancer diagnostics guidelines